Orkla India IPO GMP Today: Premium Jumps to ₹160 Ahead of Listing — Check Full GMP Trend & Listing Gains
Orkla India IPO GMP Today: The buzz around Orkla India IPO GMP today is heating up as the IPO inches closer to its opening date. Investors are tracking the grey market premium (GMP) closely, and the numbers look promising — with rates touching as high as ₹160 per share in some reports. This sharp rise in GMP indicates strong investor appetite and bullish sentiment toward the FMCG giant’s offering.
As Orkla India — known for brands like MTR and Eastern — prepares to list on Dalal Street, the Orkla India IPO is drawing attention not only for its strong brand recall but also for its potential double-digit listing gains. However, while the growing GMP trend suggests optimism, investors must remember that grey market trades are unofficial and speculative.
Here’s a detailed look at the Orkla India IPO GMP today, GMP trend movement, key dates, and what the premium really means for investors ahead of Orkla India’s much-awaited debut.
What is the Orkla India IPO GMP Today & its Trend?
Latest figures
- According to one tracker, the Orkla India IPO GMP today stands at ₹114 per share, which implies ~15.6% premium over the upper band of ₹730.
- Other sources show GMP up to ~₹160 per share, indicating ~12.9% estimated listing gain if issue at ₹730 + ₹160 = listing at ~₹890.
- Another report lists GMP ~₹130 per share.
Trend summary (Day-wise snapshot)
From IPO Central / track-sites
| Date | Reported GMP | Estimated listing gain* |
|---|---|---|
| 24 Oct 2025 | ~₹105 | ~14.4% (assuming ₹730 band) |
| 25 Oct 2025 | ~₹140 | ~19% |
| 27 Oct 2025 | ~₹115 | ~15.8% |
* Using upper issue band of ₹730 + GMP = estimated listing price.
Also note one source showing high of ~₹160 on 27 Oct.
Interpretation
- The GMP has shown upward movement as the IPO launch nears => suggesting strong demand and positive grey-market sentiment.
- The range of GMP (₹105 → ₹140 → ~₹160) suggests listing gains in double-digits (around ~15-20% or more) if the premium holds.
- But there is variation across sources (some show lower GMP ~₹70 earlier) which suggests uncertainty and consumable data quality.
What does GMP signal & caveats?
What the higher GMP suggests
- Investors in unofficial (grey) market anticipate that the listing price will be meaningfully above the issue price.
- It reflects strong aftermarket expectation/optimism in the IPO.
- It may also reflect excess demand vs supply, improving listing chances.
But remember the caveats
- Grey market is unregulated; GMP numbers are not official, may lack transparency or reliability.
- GMP is not a guarantee of actual listing gain — the stock could list at a different price depending on actual demand, market conditions, etc.
- Because it’s an OFS (no fresh issue) many shares are being sold by existing shareholders — implications for long-term valuations differ.
- Listing gains are just one facet; long-term fundamentals, company growth, valuation matter.
What Are the Key Dates for Orkla India IPO 2025?
| Particulars | Details |
|---|---|
| IPO Open Date | 29 October 2025 |
| IPO Close Date | 31 October 2025 |
| IPO Allotment Date | 3 November 2025 |
| Refund Date | 4 November 2025 |
| Demat Credit Date | 4 November 2025 |
| Listing Date | 6 November 2025 (BSE & NSE) |
| IPO Bidding Cutoff Time | 5 PM, 31 October 2025 |
What Are the Market Lot & Application Sizes?
| Investor Type | Lot Size | No. of Shares | Amount (₹) |
|---|---|---|---|
| Retail Min | 1 | 20 | 14,600 |
| Retail Max | 13 | 260 | 1,89,800 |
| S-HNI Min | 14 | 280 | 2,04,400 |
| B-HNI Min | 69 | 1,380 | 10,07,400 |
Final Thoughts
Given the data:
- The GMP level (~₹114-160) suggests a fairly healthy listing expectation, possibly listing at ~₹840-₹890 if upper band ₹730 holds.
- However, the range of GMP suggests volatility and that the premium is still moving; one should watch until closer to listing.
- If you are considering applying: Factor in the strong brand, but also remember: market may already “price in” the listing gain, leaving less upside.
- Retail investors should consider the valuation (P/E, growth prospects) and not just hunt for listing gain.
FAQ on Orkla India IPO & GMP
Q1. What is the issue price band for the Orkla India IPO?
A1. ₹695 to ₹730 per share.
Q2. What is the minimum investment (lot size) for retail investors?
A2. 20 shares (i.e., at upper band ~₹14,600).
Q3. What is the Orkla India IPO GMP today?
A3. It varies by source: some show ~₹114 per share (~15.6% premium) others show upto ~₹160.
Q4. What does GMP imply about listing gains?
A4. Roughly: issue band upper ₹730 + GMP = estimated listing price. For example, if GMP ~₹140 then implied listing ~₹870, meaning ~19% listing gain.
Q5. Is the issue a fresh issue or offer for sale?
A5. It’s an Offer for Sale (OFS) entirely – existing shareholders are selling shares; the company is not raising fresh capital.
Q6. Should I rely purely on GMP to decide whether to apply?
A6. No. GMP is only one indicator of short-term listing potential. You must also assess the company’s fundamentals, valuation, long-term prospects, lock-in terms, market conditions.
Click Here to know more market & IPO related updates and news.
Disclaimer: The views and investment insights provided here are based on publicly available information and do not constitute financial advice. Readers are advised to conduct their own research or consult certified financial experts before making investment decisions.
